GlobeImmune Cash Flow - Annual (OTCMKTS:GBIM)

Add to My Stocks
$0.55 $0.02 (3.51%) GBIM stock closing price Jun 22, 2018 (Closing)

For analyzing any company like GlobeImmune from an investment perspective, its important to check the cash flow statement. The profit-loss statement shows GlobeImmune profits, the balance sheet shows GlobeImmune debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. The cash flow statement is essetial while conducting the GlobeImmune cash flow analysis and can be used to measure the operating performance of GlobeImmune compared to various industry peers like ACUR stock and PARNF stock. GlobeImmune has a negative cash and cash equivalents change of $-6.91M.

View details of GlobeImmune cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec2015201420132012
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow----
Net Increase (Decrease) in Assets Liabilities-4.54M-4.52M-4.69M-10.39M
Cash From (used in) Discontinued Operations----
Other Adjustments Net-0.01M10.44M-1.62M-1.58M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment--0.16M-0.01M-0.1M
Acquisition Disposition of Subsidiaires----
Increase (Decrease) in Investments----
Other Cash Inflow (Outflow) from Investment Activities----
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares-17.28M--
Issuance (Repayment) of Debt Securities-7.5M--
Increase (Decrease) in Bank & Other Borrowings----
Payment of Dividends & Other Cash Distributions----
Other Cash from (used by) Financing Activities--3.68M--
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year16.81M5.92M2M15.15M
Cash & Equivalents at Year End9.9M16.81M5.92M2M
All figures in USD. M: Millions of USD, B: Billions of USD.

While GlobeImmune stock price history provides the price history of a stock, GlobeImmune stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • GlobeImmune saw a negative change in Net Change in Cash and Cash Equivalents of $-6.91M in 2015. Apart from the GlobeImmune stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-7.12M for GBIM.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $- for GBIM stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. GlobeImmune spent $- from financing activities, in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For GlobeImmune Cash Flow